Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer

Acta Cytologica

Volumn 44, Issue 3, 2000, Pages 310-318

  Costa, Silvano ^a,d   Sideri, Mario ^b   Syrjänen, Kari ^c   Terzano, Patrizia ^e   De Nuzzo, Maria ^a   De Simone, Pia ^a   Cristiani, Paolo ^a   Finarelli, Alba C ^a   Bovicelli, Alessandro ^a   Zamparelli, Alessandra ^a   Bovicelli, Luciano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e NONE

Author keywords

Cervical smears; Cervicography; Cervix neoplasms; Hybrid capture; Papillomavirus, human

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SCREENING; COLPOSCOPY; CURETTAGE; DNA DETERMINATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUNCH BIOPSY; SCREENING TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 17044449045     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000328471     Document Type: Article

References (37)

1. Modan B: Screening for cervical cancer: Should the routine be challenged? Eur J Cancer 1993;29A:2320-2325
2. Koss LG: The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA 1989;261:737-743
3. Chamberlain J: Reasons that some screening programmes fail to control cervical cancer. In Screening for Cancer of the Uterine Cervix. Edited by M Hakama, AB Miller, NE Day. Lyon, International Agency for Research on Cancer, 1986 pp 161-164
4. Mitchell H, Medley G, Giles G: Cervical cancers diagnosed after negative results on cervical cytology: Perspective in the 1980s. Br Med J 1990;300:1622-1626
5. Averette HE, Steren A, Nguyen HN: Screening in gynecologic cancers. Cancer 1993;72:1043-1049
6. Richart RM: Screening: The next century. Cancer 1995;76: 1919-1927
7. Ponten J, Adami H-O, Bergstrom R, Dillner J, Friberg L-G, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopulous D: Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26
8. Schiffman MH, Kiviat NB, Burk RD, Shah KV, Daniel RW, Lewis R, Cadell DM, Howley PM: Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33:545-550
9. Tawa K, Forsythe A, Cove KJ, Saltz A, Peters HW, Wataring WG: A comparison of the Papanicolaou smear and the cervicogram: Sensitivity, specificity, and cost analysis. Obstet Gynecol 1988;71:229-235
10. Szarewski A, Cuzik J, Edwards R, Butler B, Singer A: The use of cervicography in a primary screening service. Br J Obstet Gynaecol 1991;98:313-337
11. Ferris DG, Payne P, Frisch LE: Cervicography: An intermediate triage test for the evaluation of cervical atypia. J Fam Pract 1993;37:463-468
12. Spitzer KE, Krumholz BA, Chernys AE, Selzer V, Lightman A: Comparative utility of repeat Papanicolaou smears, cervicography and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol 1987;69:731-735
13. Reid R, Greenberg MD, Lorincz A, Jensen AB, Laverty CR, Husain M, Daoud Y, Zado B, White T, Cantor D, Goldrath M: Should cervical cytology testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991;164:1461-1471
14. Schneider A, Zahm DM, Kirchmayr R, Schneider VL: Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol 1996;174:1534-1541
15. Ferenczy A: Viral testing for genital human papillomavirus infections: Recent progress and clinical potentials. Int J Gynecol Cancer 1995;5:321-328
16. Wright TC Jr, Sun XW, Koulos J: Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85: 202-210
17. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM: An evaluation of human papillomavirus testing as part of referral to colposcopic clinic. Obstet Gynecol 1992;80:389-395
18. Cuzik J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steel ST, Guilleband J: Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-1536
19. Fait G, Daniel Y, Kupferminc MJ, Lessing JB, Niv J, Bar-Am A: Does typing papillomavirus assist in the triage of women with repeated low-grade cervical cytologic abnormalities? Gynecol Oncol 1998;70:319-322
20. Carlson JW, Twiggs LB: Clinical applications of molecular biologic screening for human papillomavirus: Diagnostic techniques. Clin Obstet Gynecol 1992;35:13-21
21. Hoffman MS, Cavanagh D: Cervical cancer. In Cancer Screening. Edited by DS Reitgen, RA Clark. St Louis, CV Mosby, 1996, pp 41-54
22. Costa S, Sideri M, Bucchi L, Schettino F, Maini M, Spinaci L, Bovicelli L, Terzano P: Cervicography and HPV DNA testing as triage criteria for patients with abnormal Pap smear. Gynecol Oncol 1998;71:404-409
23. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Acta Cytol 1993;37:115-124
24. Gardner MJ, Altman DG: Confidence intervals rather than p values: Estimation rather than hypothesis testing. Br Med J 1986;292:746-750
25. Armitage P, Berry G: Statistical Methods in Medical Research. Second edition. Oxford, Blackwell, 1987, pp 117-120
26. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, De Rouen TA, Galloway DA, Vernon D, Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278
27. Jones HW III: Impact of the Bethesda System. Cancer 1995;6: 1914-1948
28. Cocchi V, Sintoni C, Carretti D, Sama D, Chiari U, Segala V, Delazer AL, Grilli N, Papaleo R, Ghirardini C, Bucchi L: External quality assurance in cervical/vaginal cytology: Interlaboratory agreement in the Emilia-Romagna region of Italy. Acta Cytol 1996;40:480-488
29. Sama D, Cotignoli T, Guerrini L, Maioli P, Bucchi L: Intralaboratory reproducibility of cervical cytology diagnoses in the external quality assurance scheme of the Emilia-Romagna region of Italy. Gynecol Oncol 1996;60:404-408
30. Cox T, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ: Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-954
31. Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, Irwin J, Simon T, Press M, Uhler R, Entman C, Reeves WC. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997;176:87-92
32. Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves W: Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 1998;178:1235-1244
33. Hatch KD, Schneider A, Abdel-nour MW: An evaluation of human papillomavirus testing for intermediate and high risk types before colposcopy. Am J Obstet Gynecol 1995; 1172:1150-1157
34. Patrik J: Has screening for cervical cancer been successful? Br J Obstet Gynaecol 1997;104:876-878
35. Taromaru EK, Gallo C, Dores GB: Biologia Molecular da deteccao de DNA HPV: Correlacao entre duas geracoes de Captura Hibrida. Presented at the XII Congresso Latino-Americano de Doencas Sezalmente Transmissiveis, Salvador Bahia, Brazil, September 8-11, 1999
36. Sellors JW, Nieminen P, Vesterinen E, Paavonen J: Observer variability in the scoring of colpophotographs. Obstet Gynecol 1990;76:1006-1008
37. Kaufman RH, Adam E: Does typing papillomavirus assist in the triage of women with repeated low-grade cervical cytologic abnormalities? Gynecol Oncol 1998;70:317-381